The U.S. ethical nutrition market will reach $8 billion in 2007. The growing number of elderly and critically ill, along with a shift towards home care is fueling growth.
By 2012, it is anticipated that revenues will likely reach $9 billion, expanding at a compound annual growth rate of 2.3%.
The total U.S. ethical nutrition market was dominated by infant and pediatric nutritionals. In 2007, this will account for approximately 33% of total revenues.
Report Code: FOD029C, Published: June 2007, Analyst: Mary Anne Crandall
INTRODUCTION
The objectives of this study are to present an updated, in-depth look at ethical nutrition in healthcare. Markets are divided according to product type. It is directed to decision-makers involved with the various types of nutritional products covered, and designed to present insights into those areas associated with current and future developments.
This BCC Research study revisits the field of ethical nutrition in healthcare. It was of great interest in the early 1990s, but has not generated much interest over the last few years. However, due to the increased numbers of adults requiring ethical nutritional therapy, there has been renewed interest in the market. The study identifies products and manufacturers that are operating in the market, and analyzes the changing environment of ethical nutrition. Issues and trends that are shaping the market are addressed, along with future trends and opportunities in ethical nutrition.
SCOPE OF STUDY
This report:
Profiles and measures the U.S. market for ethical nutrition in healthcare with comprehensive focus on markets for infant and adult enteral and parenteral nutrition and nutritional supplies and equipment.
Includes a comparative overview of nutrition and its function in the human body, as well as definitions of products and product types within each market as well ethical nutrition supplies and equipment.
Analyzes all market segments with forecasts by sector and sub-sector through 2011.
Includes analysis of regulatory issues and industry structure, R&D updates, and patent analysis.
METHODOLOGY AND INFORMATION SOURCES
The information and analyses presented in this report are based on extensive first hand interviews with primary executives, product managers, and clinical specialists in the area of ethical nutrition. Random surveying provided information about product use and how products are obtained. Background information was obtained from various government and business sources, medical journals, and trade magazines as well as interviews with doctors and dieticians.
Key information from published literature was used as a basis for conducting interviews with more than 21 industry participants to validate and obtain expert opinions on current and future trends in ethical nutrition in healthcare. Interviews also were used to confirm and/or adjust market size and competitor market share estimates, as well as to formulate market projections.
All data pertain to the U.S. market at the manufacturer's level. Data are expressed in current U.S. dollars. The base year was 2007; historical data are provided for 2005 and 2006, and forecast data are provided for 2012. Historical, base year and forecast data are provided for each market segment and subsegment. Market share information is provided for each market subsegment for the 2007 base year.
ANALYST CREDENTIALS
Mary Anne Crandall has been publishing market research in the life sciences for more than 17 years. She holds a Master of Science Degree in psychology, and is the founder and CEO of Mountaintop Medical, LLC, a consulting firm in Oregon. She has taught at Southern Oregon University for more than 16 years, and before joining BCC's analytical team, she published with Frost & Sullivan, Theta Reports, FIND/SVP, MDI, FeedBack Research Services, Prognosis and Hall Enterprises. Ms. Crandall specializes in prescription pharmaceutical markets.
Report Code: FOD029C, Published: June 2007, Analyst: Mary Anne Crandall
RELATED BCC REPORTS
CHM034B The Global Market for Flavors and Fragrances
